CUMBERLAND PHARMACEUTICALS INC (CPIX)
$0.00+$0.00 (+0.00%) Latest sessionExtended Hours
Latest CPIX Insider Trades
Caroline Young - DirectorOpen-market purchase
Caroline Young - DirectorCaroline Young - DirectorCaroline Young - DirectorCaroline Young - DirectorCaroline Young - DirectorCaroline Young - DirectorCaroline Young - DirectorCaroline Young - DirectorCumberland Pharmaceuticals Inc is a specialty pharmaceutical company focused on the acquisition, development, and commercialization of branded prescription pharmaceutical products. The Company has one operating segment, which is specialty pharmaceutical products. The company's target markets are hospital acute care, gastroenterology, rheumatology, and oncology. The firm promotes its approved products through its hospital, field, and oncology sales divisions in the United States and establishes a network of international partners to register and provide medicines to patients in their countries. Its brands include Acetadote, Caldolor, Kristalose, Sancuso, Vaprisol, and Vibativ. Geographically, the company generates revenue from China, South Korea, Russia, Mexico, Australia, and Saudi Arabia.
https://www.cumberlandpharma.comSEC filings for CPIX on EDGAR
No Form 4 activity for CPIX in the last 90 days.
63 Form 4 filings on record, the earliest from Oct 3, 2024, newest first. Filing history page 3 of 3.
| Date | Insider | Transaction | Security | Shares | Price | Value |
|---|---|---|---|---|---|---|
 A. J. Kazimi - Officer | Other | Common Stock | 50 | $1.38 | $69 | |
| A. J. Kazimi - Officer | Other | Common Stock | 47 | $1.35 | $63 | |
| A. J. Kazimi - Officer | Other | Common Stock | 46 | $1.28 | $59 | |
| A. J. Kazimi - Officer | Other | Common Stock | 10 | $1.30 | $13 | |
| A. J. Kazimi - Officer | Other | Common Stock | 50 | $1.33 | $67 | |
| A. J. Kazimi - Officer | Other | Common Stock | 31 | $1.30 | $40 | |
| A. J. Kazimi - Officer | Other | Common Stock | 48 | $1.35 | $65 | |
| A. J. Kazimi - Officer | Other | Common Stock | 50 | $1.38 | $69 | |
| A. J. Kazimi - Officer | Other | Common Stock | 50 | $1.30 | $65 | |
| A. J. Kazimi - Officer | Other | Common Stock | 50 | $1.30 | $65 | |
| A. J. Kazimi - Officer | Other | Common Stock | 50 | $1.30 | $65 | |
| A. J. Kazimi - Officer | Other | Common Stock | 50 | $1.30 | $65 | |
| A. J. Kazimi - Officer | Other | Common Stock | 50 | $1.29 | $65 | |
| A. J. Kazimi - Officer | Other | Common Stock | 50 | $1.30 | $65 | |
| A. J. Kazimi - Officer | Other | Common Stock | 50 | $1.25 | $63 | |
| A. J. Kazimi - Officer | Other | Common Stock | 15 | $1.22 | $18 | |
| A. J. Kazimi - Officer | Other | Common Stock | 39 | $1.29 | $50 | |
| A. J. Kazimi - Officer | Other | Common Stock | 50 | $1.24 | $62 | |
| A. J. Kazimi - Officer | Other | Common Stock | 44 | $1.24 | $55 | |
| A. J. Kazimi - Officer | Other | Common Stock | 62 | $1.36 | $84 | |
| Caroline Young - Director | Other | Common Stock | 25 | $1.38 | $35 | |
| Caroline Young - Director | Other | Common Stock | 23 | $1.35 | $31 | |
| Caroline Young - Director | Other | Common Stock | 23 | $1.28 | $29 | |
| Caroline Young - Director | Other | Common Stock | 6 | $1.30 | $8 | |
| Caroline Young - Director | Other | Common Stock | 25 | $1.33 | $33 | |
| Caroline Young - Director | Other | Common Stock | 15 | $1.30 | $20 | |
| Caroline Young - Director | Other | Common Stock | 24 | $1.35 | $32 | |
| Caroline Young - Director | Other | Common Stock | 25 | $1.35 | $34 | |
| Caroline Young - Director | Other | Common Stock | 25 | $1.30 | $33 | |
| Caroline Young - Director | Other | Common Stock | 25 | $1.30 | $33 | |
| Caroline Young - Director | Other | Common Stock | 25 | $1.30 | $33 | |
| Caroline Young - Director | Other | Common Stock | 25 | $1.30 | $33 | |
| Caroline Young - Director | Other | Common Stock | 25 | $1.29 | $32 | |
| Caroline Young - Director | Other | Common Stock | 25 | $1.30 | $33 | |
| Caroline Young - Director | Other | Common Stock | 25 | $1.25 | $31 | |
| Caroline Young - Director | Other | Common Stock | 7 | $1.22 | $9 | |
| Caroline Young - Director | Other | Common Stock | 20 | $1.29 | $26 | |
| Caroline Young - Director | Other | Common Stock | 25 | $1.24 | $31 | |
| Caroline Young - Director | Other | Common Stock | 22 | $1.24 | $27 | |
| Caroline Young - Director | Other | Common Stock | 31 | $1.36 | $42 | |
 Kenneth Krogulski - Director | Other | Common Stock | 250 | $1.38 | $345 | |
| Kenneth Krogulski - Director | Other | Common Stock | 238 | $1.35 | $321 | |
| Kenneth Krogulski - Director | Other | Common Stock | 230 | $1.28 | $294 | |
| Kenneth Krogulski - Director | Other | Common Stock | 52 | $1.30 | $68 | |
| Kenneth Krogulski - Director | Other | Common Stock | 250 | $1.33 | $333 | |
| Kenneth Krogulski - Director | Other | Common Stock | 153 | $1.30 | $199 | |
| Kenneth Krogulski - Director | Other | Common Stock | 241 | $1.35 | $325 | |
| Kenneth Krogulski - Director | Other | Common Stock | 250 | $1.35 | $338 | |
| Kenneth Krogulski - Director | Other | Common Stock | 250 | $1.30 | $325 | |
| Kenneth Krogulski - Director | Other | Common Stock | 250 | $1.30 | $325 | |
| Kenneth Krogulski - Director | Other | Common Stock | 250 | $1.30 | $325 | |
| Kenneth Krogulski - Director | Other | Common Stock | 250 | $1.30 | $325 | |
| Kenneth Krogulski - Director | Other | Common Stock | 250 | $1.29 | $323 | |
| Kenneth Krogulski - Director | Other | Common Stock | 250 | $1.30 | $325 | |
| Kenneth Krogulski - Director | Other | Common Stock | 250 | $1.25 | $313 | |
| Kenneth Krogulski - Director | Other | Common Stock | 73 | $1.22 | $89 | |
| Kenneth Krogulski - Director | Other | Common Stock | 197 | $1.29 | $254 | |
| Kenneth Krogulski - Director | Other | Common Stock | 250 | $1.24 | $310 | |
| Kenneth Krogulski - Director | Other | Common Stock | 221 | $1.24 | $274 | |
| Kenneth Krogulski - Director | Other | Common Stock | 309 | $1.36 | $420 |
This is as far as the anonymous view goes. Create a free account for all 63 CPIX filings on record.
CUMBERLAND PHARMACEUTICALS INC (CPIX) has filed no insider reports in the last 90 days. The most recent on record is dated 2026-03-20. The full record for CPIX runs to 63 Form 4 filings, the earliest from 2024-10-03. InsiderAlpha tracks every Form 4, Form 144, and 8-K filing in real time.
No insider purchases of CPIX were filed in the last 90 days. 736 purchases are on record for this company.
No insider sales of CPIX were filed in the last 90 days.
This page tracks CPIX Form 4 insider transactions, Form 144 sale notices, and 8-K material event disclosures in one timeline. Annual 10-K and quarterly 10-Q reports live on the company's SEC EDGAR page.
Create a free InsiderAlpha account and press Watch on this page to add CPIX to your watchlist. A free account also opens the full scored daily plan with every past day and 3 months of price history. No card is required. Sign up at https://insideralpha.ai/register.
$CPRXCATALYST PHARMACEUTICALS, INC.
$CRBPCorbus Pharmaceuticals Holdings, Inc.
$CRBUCaribou Biosciences, Inc.
$CRDFCardiff Oncology, Inc.
$CRGTCortigent, Inc.
$CRGXCARGO Therapeutics, Inc.
$CRISCURIS INC
$CRLCHARLES RIVER LABORATORIES INTERNATIONAL, INC.
$CRMDCorMedix Inc.
$CRNXCrinetics Pharmaceuticals, Inc.Every Form 4 below links to the original document on SEC EDGAR, so the numbers on this page can be checked against the filing they came from.
Real-time Form 4 alerts, AI-scored daily trade ideas and 10b5-1 plan flags.
